Clarapath

Clarapath is a private, commercial-stage company pioneering automation in anatomical pathology through its SectionStar robotics platform. The company addresses critical laboratory bottlenecks by automating the manual, skilled-intensive process of tissue sectioning, which can reduce turnaround times, improve slide consistency, and enable remote operation. With its systems manufactured in an ISO 13485-certified facility in New York, Clarapath targets both human clinical diagnostics and animal healthcare/research markets, positioning itself as a leader in modernizing traditional histology workflows with precision engineering and digital tools.

Proprietary robotics and tape-transfer system for automated tissue sectioning and slide preparation, integrated with machine vision, precision motion controls, and remote telehistology software.

Clarapath is a first-mover in fully automated tissue sectioning, a niche with limited direct competitors. However, it competes indirectly with traditional microtome manufacturers (e.g., Leica Biosystems, Sakura) and broader laboratory automation companies. Its primary competition is the entrenched manual status quo, but as the market validates automation, larger players may enter with competing systems.